Skip to Main Content

Paper Details

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.
Virchows Arch
9
2022
Author NameAffiliation
Joshua MillsteinKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Aline TalhoukVancouver General Hospital, and University of British Columbia
Aline TalhoukUniversity of British Columbia
Aline TalhoukUniversity of British Columbia
Derek S ChiuVancouver General Hospital, and University of British Columbia
Michael S AnglesioUniversity of British Columbia
Michael S AnglesioCancer Research UK Cambridge Institute, University of Cambridge
Michael S AnglesioUniversity of British Columbia
Michael S AnglesioUniversity of British Columbia
Michael S AnglesioCancer Research UK Cambridge Institute, University of Cambridge
Michael S AnglesioUniversity of British Columbia
Diether LambrechtsVIB Center for Cancer Biology
Diether LambrechtsUniversity of Leuven
Jes??s Garc??a-DonasUniversity Hospital
Andreas du Bois
Andreas du Bois
Jenny LesterDavid Geffen School of Medicine, University of California at Los Angeles
Sebastian M ArmasuDivision of Clinical Trials and Biostatistics, Mayo Clinic
Chen WangMayo Clinic
Stacey J WinhamMayo Clinic
Malcolm C PikeKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Malcolm C PikeMemorial Sloan-Kettering Cancer Center
Malcolm C PikeKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Malcolm C PikeMemorial Sloan-Kettering Cancer Center
Chiu-Chen TsengKeck School of Medicine, University of Southern California
Celeste Leigh PearceKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Celeste Leigh PearceKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Thomas P ConradsWomen's Health Integrated Research Center, Inova Health System
Yovanni CasablancaUniformed Services University of the Health Sciences
Alison BrandWestmead Hospital
Paul HarnettThe Crown Princess Mary Cancer Centre Westmead, Westmead Hospital
Paul HarnettThe University of Sydney
Catherine J KennedyThe Westmead Institute for Medical Research
Catherine J KennedyWestmead Hospital
Peter A FaschingComprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU)
Peter A FaschingDavid Geffen School of Medicine, University of California at Los Angeles
George L MaxwellInova Health System
Beth Y KarlanDavid Geffen School of Medicine, University of California at Los Angeles
Ellen L GoodeMayo Clinic
Hans-Peter SinnInstitute of Pathology, University Hospital Heidelberg
Stefan KommossTubingen University Hospital
Stefan KommossTubingen University Hospital
Anna H WuKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Anna H WuKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Anna DeFazioThe Westmead Institute for Medical Research
Anna DeFazioThe University of Sydney
Anna DeFazioThe Crown Princess Mary Cancer Centre Westmead, Westmead Hospital
Anna DeFazioWestmead Hospital
  • 1 - 50

Datasets